2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · IEX Real-Time Price · USD
3.760
-0.100 (-2.59%)
Jun 25, 2024, 3:13 PM EDT - Market open

2seventy bio Revenue

2seventy bio had revenue of $71.20M in the twelve months ending March 31, 2024, down -42.90% year-over-year. Revenue in the quarter ending March 31, 2024 was $12.44M, a -70.12% decrease year-over-year. In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth.

Revenue (ttm)
$71.20M
Revenue Growth
-42.90%
P/S Ratio
2.70
Revenue / Employee
$259,858
Employees
274
Market Cap
193.80M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023100.39M8.89M9.72%
Dec 31, 202291.50M36.97M67.81%
Dec 31, 202154.52M-193.60M-78.03%
Dec 31, 2020248.12M203.83M460.15%
Dec 31, 201944.30M-10.28M-18.84%
Dec 31, 201854.58M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Butterfly Network 68.08M
EDAP TMS 65.80M
Genfit 42.42M
Nanobiotix 40.23M
bluebird bio 21.73M
Inovio Pharmaceuticals 717.07K
Sera Prognostics 206.00K
Revenue Rankings